Ediciones Finlay • Biotechnology (new generation of adjuvants and vaccine ) with IFAL. UH. Chief of Writing. Specialist of the Ediciones Finlay Department. Specialist of Scientific Redaction and Edition. Vicepresidency of Commercial. Finlay Institute, Cuba.

Name and last names: Daniel Francisco Arencibia Arrebola. Date of birth: September 5 1981. D.N.I: 81090506706. Civil state: Single. Citizenship: Cuban. Particular address: 72 street, #2521, First apartment, between 25 and 27 avenue, Playa Municipality, Havana City. The Veterinary Medical Doctor Daniel Francisco Arencibia Arrebola, MSc, PhD, has more than 8 years of work in scientist technique working in the field of research-development of new therapeutic principles. He has more than 120 publications in arbitrated international and national journal, more than 50 graduate degree courses in the thematic of biotechnology, immunology, veterinary microbiology, epidemiology, English language and international system of regulations for clinical research and registrations of biological products. He has more than 60 presentations in international and national events in format poster, oral presentation and conferences. In addition, He has more than 20 received scientific distinctions and he has been tutor of six thesis in option to Bachelor Science. Their work has been centering in the search of new natural sources for use therapeutic, new vaccine formulations and preclinical toxicology evaluation of different biological products and medications obtained starting from natural sources. He is active referee of the REDVET, VacciMonitor and Andrology Journal. He has great experience in the preclinical regulatory field of biological products and he has an International Diplomat at distance in Veterinary Epidemiology, Master in Veterinary Microbiology, and scientific category of Aggregated Research. He has a PhD in Health Sciences (2012-2014). Now is the Chief of Writing of the editorial Finlay Editions, belonging to the Commercial Vice-presidency of the Finlay Institute.